One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
| Cockcroft-Gault CrCl | Oral regimen |
|---|---|
| Above 50 through 95 mL/min | 60 mg once daily |
| 15 through 50 mL/min | 30 mg once daily |
| Above 95 mL/min | Do not use for NVAF; choose another anticoagulant |
The high-clearance restriction reflects reduced efficacy for NVAF and is not a low-renal-function precaution.
RDM32-edoxaban-savaysa-1 · Source locator: Boxed warning; 2.1; 5.1
After 5-10 days of parenteral anticoagulation, the usual labeled dose is 60 mg once daily. Reduce to 30 mg once daily for CrCl 15-50 mL/min, body weight at or below 60 kg, or specified P-gp inhibitors. This summary does not provide an ESRD or dialysis regimen.
RDM32-edoxaban-savaysa-2 · Source locator: 2.2; 8.6
Selected renal sections only, not a complete monograph. Exact product, indication, patient population, renal method and all other contraindications/interactions remain controlling.
Second independent renal reference and clinician adjudication remain pending; no all-indication, dialysis or pediatric dose may be inferred from an omitted field.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=edoxaban-savaysa&s1=RDM32-label-edoxaban-savaysa&h1=70f7e89d05e5cf4181b051eb70da527a2402e051f0b229eeb944d679825aeb87